{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:35:08Z","timestamp":1789799708921,"version":"4.0.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cardiovascular diseases, notably myocardial infarction (MI), contribute significantly to global mortality. While traditional MIs are often associated with notable coronary artery blockages, a subgroup experiences MI without such blockages, termed myocardial infarction with nonobstructive coronary arteries (MINOCA). Current diagnostic methods, like invasive coronary angiograms, are inadequate in diagnosing MINOCA due to the absence of visible vessel blockages. Personalized medicine endeavors to introduce novel diagnostic tools for early identification and tailored management of MINOCA. Unlike percutaneous coronary intervention, which lacks efficacy in MINOCA, personalized medical management aligned with the specific underlying pathophysiological cause is essential. Treatments may include statins, agents modulating the renin-angiotensin system, and antiplatelet therapies if linked to plaque disruption. At the same time, calcium channel blockers may be pivotal if coronary artery spasm is the primary cause. Research is ongoing to refine tailored therapies and discover new biomarkers, highlighting the crucial need for individualized approaches in managing MINOCA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000000707","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T09:06:53Z","timestamp":1714122413000},"page":"322-327","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Role of Personalized Medicine in Myocardial Infarction With Nonobstructive Coronary Artery Disease (MINOCA): An Updated Review"],"prefix":"10.1097","volume":"34","author":[{"given":"Deepak","family":"Kumar","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu","family":"Nirander","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnain","family":"Raza","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rani","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirthvi","family":"Raj","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu","family":"Adnan","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahanzeb","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cardiovascular Analytics Group, Islamabad, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2012.07.064","article-title":"Pathogenesis of acute coronary syndromes.","volume":"61","author":"Crea","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American heart association.","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"79","DOI":"10.15420\/ecr.2015.10.2.79","article-title":"Myocardial infarction with non-obstructive coronary arteries \u2013 diagnosis and management.","volume":"10","author":"Pasupathy","year":"2015","journal-title":"Eur Cardiol Rev"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.mjafi.2021.06.021","article-title":"Precision medicine: concept and tools.","volume":"77","author":"Naithani","year":"2021","journal-title":"Med J Armed Forces India"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine.","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"R9-20260605","first-page":"20560","article-title":"Glutathione infusion before and 3 days after primary angioplasty blunts ongoing NOX2-mediated inflammatory response.","volume":"10","author":"Tanzilli","year":"2021","journal-title":"J Am Hear Assoc"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.2020.12443","article-title":"Effect of genotype-guided oral P2Y12 inhibitor selection vs conventional clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI randomized clinical trial.","volume":"324","author":"Pereira","year":"2020","journal-title":"JAMA"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.4244\/EIJ-D-22-00178","article-title":"Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial.","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/jcm12103586","article-title":"Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): focus on coronary microvascular dysfunction and genetic susceptibility.","volume":"12","author":"Severino","year":"2023","journal-title":"J Clin Med"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review.","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1142842","article-title":"A common variant on chromosome 9p21 affects the risk of myocardial infarction.","volume":"316","author":"Helgadottir","year":"2007","journal-title":"Science"},{"key":"R17-20260605","first-page":"522","article-title":"A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression in brief a common sequence variant that perturbs long-range enhancer interactions mediates risk for different vascular diseases. Article a genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression.","volume":"170","author":"Rajat Gupta","year":"2017","journal-title":"Cell"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/cardiogenetics13020006","article-title":"Prevalence of polymorphisms of genes responsible for coagulation system and folate metabolism and their predictive value for thrombosis development in MINOCA patients: immediate and long-term prognoses.","volume":"13","author":"Kruchinova","year":"2023","journal-title":"Cardiogenetics"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jjcc.2021.01.001","article-title":"Myocardial infarction with non-obstructive coronary arteries (MINOCA): intracoronary imagingbased diagnosis and management.","volume":"77","author":"Sucato","year":"2021","journal-title":"J Cardiol"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"e013235","DOI":"10.1161\/JAHA.119.013235","article-title":"Coronary inflammation by computed tomography pericoronary fat attenuation in MINOCA and Tako-Tsubo syndrome.","volume":"8","author":"Gaibazzi","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"346","DOI":"10.14715\/cmb\/2021.67.6.45","article-title":"Leukocyte telomere length and lipid parameters in patients with myocardial infarction with non-obstructive coronary arteries.","volume":"67","author":"Inandiklioglu","year":"2022","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2018.05.077","article-title":"MINOCA \u2013 a personalised medicine approach.","volume":"267","author":"Tavella","year":"2018","journal-title":"Int J Cardiol"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease.","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1253\/circj.CJ-15-1202","article-title":"The who, what, why, when, how and where of vasospastic angina.","volume":"80","author":"Beltrame","year":"2016","journal-title":"Circ J"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"ESC Committee for Practice Guidelines (CPG).","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tips.2016.11.007","article-title":"Implementing precision medicine: the ethical challenges.","volume":"38","author":"Korngiebel","year":"2017","journal-title":"Trends Pharmacol Sci"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:01:05Z","timestamp":1780671665000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000707","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}